SAN RAFAEL, Calif.--(BUSINESS WIRE)--BioCision, LLC, the leading developer of advanced thermal technologies for biospecimen handling and standardization, today announced the company has moved its global headquarters to San Rafael, California.
The newly renovated office, located at 101 Glacier Point Road, Suite E, reflects the company’s accelerated growth due to rapid adoption of its thermal regulation products by its life science and healthcare industry customers.
With a creative and open floor plan that encourages collaboration between departments, as well as warehouse facilities, BioCision will leverage the new space to continue to expand its workforce and create innovative products to meet unmet customer needs.
BioCision’s decision to move its headquarters to San Rafael is the latest in a growing trend of innovative biotech firms that have chosen Marin County as the place to expand their business,” said Gary Phillips, Mayor of San Rafael. “San Rafael offers a highly talented workforce, a local government committed to assisting businesses and a biotech business climate that inspires innovation. I would like to personally welcome BioCision to San Rafael and wish the company continued success.”
“Our new headquarters reflects the confidence we have in our strategy and continued financial and operational success, made possible by the strength of our business model, the passion of our staff and our ability to provide unique solutions for leading pharmaceutical and biotech companies," said Hugh Douglas, BioCision Chief Operating Officer. "It also reflects our commitment to equip our current and future employees with the workspace and tools they need to thrive.”
About BioCision, LLC
BioCision is a life science research and development company that develops products and solutions for process standardization throughout the healthcare industry through the application of advanced thermal regulation principles and technologies. The intuitive design and interconnectivity of BioCision products enables researchers, clinicians and manufacturers to protect the integrity of temperature-sensitive therapeutics, biological samples, and biomaterials. By comprehensively addressing temperature stability, BioCision strives to improve the success of therapeutic discovery and development and enable effective care delivery.
Visit http://www.biocision.com/and our blog for news and expert insight. Follow us on Twitter and Facebook.